Journal of Substance Abuse Treatment
Volume 30, Issue 3 , Pages 213-217 , April 2006

High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes

  • David Kalman, Ph.D.

      Affiliations

    • Department of Psychiatry, School of Medicine, Boston University, Boston, MA 02118, USA
    • Edith Nourse Rogers Memorial Veterans Administration Medical Center, Bedford, MA 01730, USA
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, School of Medicine, Boston University, Boston, MA 02118, USA.
  • ,
  • Christopher W. Kahler, Ph.D.

      Affiliations

    • Center for Alcohol and Addictions Studies, Brown University, Providence, RI 02912, USA
  • ,
  • Arthur J. Garvey, Ph.D.

      Affiliations

    • School of Dental Medicine, Harvard University, Cambridge, MA 02115, USA
  • ,
  • Peter M. Monti, Ph.D.

      Affiliations

    • Center for Alcohol and Addictions Studies, Brown University, Providence, RI 02912, USA
    • Veterans Administration Medical Center, Providence, RI 02908, USA

Received 21 November 2005 ,Accepted 6 January 2006.

References 

  1. Agency for Health Care Policy and Research (AHCPR) . The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. Journal of the American Medical Association. 1996;275:1270–1280
  2. Benowitz NL. Nicotine replacement therapy: What has been accomplished—Can we do better?. Drugs. 1993;45:157–190
  3. Burling TA, Seidner Burling A, Latini D. A controlled smoking cessation trial for substance dependent inpatients. Journal of Consulting and Clinical Psychology. 2001;69:295–304
  4. Centers for Disease Control and Prevention . Cigarette smoking among adults—United States, 1994. Morbidity and Mortality Weekly Report. 1996;45:588–590
  5. Cooney NL, Litt MD, Cooney JL. In vivo assessment of the effects of smoking cessation in alcoholic smokers. Alcoholism, Clinical and Experimental Research. 2002;26:1952–1953
  6. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. Journal of the American Medical Association. 1995;274:1353–1358
  7. First MD, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV Axis I disorders. New York: New York State Psychiatric Institute; 1995;
  8. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addictions. 1991;84:791–800
  9. Hughes J. Clinical implications of the association between smoking and alcoholism. In:  Fertig JB,  Allen JP editor. Alcohol and tobacco: From basic science to clinical practice. Bethesda, MD: National Institutes on Health; 1995;p. 171–786
  10. Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, et al. Are higher doses of nicotine replacement more effective for smoking cessation?. Nicotine and Tobacco Research. 1999;2:169–174
  11. Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kotkke TE, Morse RM, et al. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. Journal of the American Medical Association. 1996;275:1097–1103
  12. Hurt RD, Pattern CA, Offord KP, Croghan IT, Decker PA, Morris RA, et al. Treating nondepressed smokers with alcohol dependence in sustained full remission: Nicotine patch therapy tailored to baseline serum cotinine. Journal of Studies on Alcohol. 2005;66:506–516
  13. Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, et al. Varying nicotine patch dose and type of smoking cessation counseling. Journal of the American Medical Association. 1995;274:1347–1352
  14. Kalman D. Smoking cessation treatment for substance misusers in early recovery: A review of the literature and recommendations for practice. Substance Use and Misuse. 1998;33:2021–2047
  15. Kalman D, Tirch D, Kahler C, Penk W, Kaschub C, Monti PM. Twelve-week outcomes from an investigation of high dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychology of Addictive Behaviors. 2004;18:78–82
  16. Krishnan-Sarin S, Meandzija B, O'Malley S. Naltrexone and nicotine patch smoking cessation: A preliminary study. Nicotine and Tobacco Research. 2003;5:851–857
  17. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22
  18. Monti PM, Rohsenow DJ, Colby SM, Abrams DB. Smoking among alcoholics during and after treatment: Implications for models, treatment strategies, and policy. In:  Fertig JB,  Allen JP editor. Alcohol and tobacco: From basic science to clinical practice. Bethesda, MD: National Institutes on Health; 1995;p. 187–206
  19. Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology. 2004;72:1144–1156
  20. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:385–401
  21. Sachs DPL. Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers. Archives of Internal Medicine. 1995;155:1973–1980
  22. Shiffman S, Balabanis M. Associations between alcohol and tobacco. In:  Fertig JB,  Allen JP editor. Alcohol and tobacco: From basic science to clinical practice. Bethesda, MD: National Institutes on Health; 1995;p. 17–36NIAAA Research Monograph No. 30
  23. Sussman S. Smoking cessation among persons in recovery. Substance Use and Misuse. 2002;37:1275–1298
  24. Transdermal Nicotine Study Group . Transdermal nicotine for smoking cessation. Journal of the American Medical Association. 1991;266:3133–3138

 A limited portion of the manuscript was presented as an abstract at the annual conference of the Society for Research on Nicotine and Tobacco (New Orleans, LA, March 2003).

PII: S0740-5472(06)00003-1

doi: 10.1016/j.jsat.2006.01.001

Journal of Substance Abuse Treatment
Volume 30, Issue 3 , Pages 213-217 , April 2006